Odds Ratio | Confidence Interval | P-value | |
---|---|---|---|
Race | |||
Black | Reference | ||
White | 1.47 | 0.50–4.32 | p = 0.48 |
Hispanic | 1.34 | 0.43–4.19 | p = 0.62 |
Other | 0.42 | 0.05–3.74 | p = 0.43 |
Age | 0.96 | 0.93–1.00 | p = 0.08 |
Gender | |||
Male | Reference | ||
Female | 0.20 | 0.03–1.33 | p = 0.10 |
Insurance | |||
Private | Reference | ||
Medicare | 0.48 | 0.13–1.84 | p = 0.29 |
Medicaid | 0.69 | 0.08–5.77 | p = 0.74 |
Self | 0.23 | 0.03–1.57 | p = 0.13 |
Income by ZIP code* | |||
Quartile 1 | Reference | ||
Quartile 2 | 3.61 | 0.95–13.67 | p = 0.06 |
Quartile 3 | 5.35 | 1.35–21.26 | p = 0.017 |
Quartile 4 | 4.38 | 1.00–19.13 | p = 0.049 |
Risk factors | |||
HTN | 6.85 | 2.68–17.52 | p = 0.0001 |
HLD | 1.07 | 0.41–2.81 | p = 0.90 |
CAD | 0.15 | 0.01–1.63 | p = 0.12 |
Arrhythmia | 1.82 | 0.35–9.52 | p = 0.48 |
DM | 1.78 | 0.67–4.75 | p = 0.25 |
Smoking | 1.18 | 0.47–2.99 | p = 0.73 |
FH | 0.79 | 0.29–2.13 | p = 0.64 |
Age > 65 | 4.01 | 0.10–16.17 | p = 0.051 |
Cancer type | |||
Breast cancer | Reference | ||
Other cancer^ | 0.12 | 0.02–0.74 | p = 0.02 |
Cancer stage | |||
Stage 1 | Reference | ||
Stage 2 | 0.31 | 0.05–1.83 | p = 0.20 |
Stage 3 | 0.16 | 0.02–1.33 | p = 0.09 |
Stage 4 | 0.23 | 0.03–1.78 | p = 0.16 |
Chemotherapy | |||
Doxorubicin | 1.49 | 0.34–6.53 | p = 0.60 |
Herceptin | 0.70 | 0.12–3.97 | p = 0.68 |
Medications pre-chemotherapy | |||
BB | 2.04 | 0.46–9.06 | p = 0.35 |
ACEI/ARB | 0.16 | 0.04–0.70 | p = 0.01 |
Diuretic | 2.31 | 0.24–22.47 | p = 0.47 |
CCB | 1.28 | 0.28–5.91 | p = 0.75 |
ASA | 2.28 | 0.42–12.49 | p = 0.34 |
Statin | 0.66 | 0.12–3.63 | p = 0.63 |